STAAR Surgical Company (STAA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on February 2, 2026, regarding events occurring on February 1, 2026. STAAR Surgical Company, a Delaware corporation, announced significant changes to its executive leadership structure following a Cooperation Agreement with Broadwood Partners, L.P. and its affiliates.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on corporate governance and executive compensation arrangements.
Material Changes
- Executive Departure: Stephen C. Farrell stepped down as Chief Executive Officer effective January 31, 2026.
- Leadership Appointment: Warren Foust (President and COO) and Deborah Andrews (CFO) were appointed as Interim Co-Chief Executive Officers effective February 1, 2026.
- Search Initiated: The Board established a Search Committee to conduct a global search for a permanent CEO, considering both internal and external candidates.
Compensation, Risks, and Contingencies
Compensation Arrangements:
- Both Interim Co-CEOs received Restricted Stock Units (RSUs) with a grant date fair value of $375,000 each, vesting on August 1, 2026.
- Mr. Foust entered a Letter Agreement providing additional benefits if he is not offered the permanent CEO role. If terminated without Cause or for Good Reason during the interim term, he is eligible for accelerated vesting of unvested awards and, if termination occurs before March 28, 2026, a remaining cash retention award of $250,000.
Risks and Contingencies:
- The interim leadership structure is temporary, with a defined term ending on August 1, 2026, or upon the announcement of a permanent CEO.
- Compensation liabilities are contingent on the outcome of the CEO search and potential termination events.
Investor Verification Checklist
- Verify the timeline and criteria for the global CEO search initiated by the Board.
- Review the specific terms of the Cooperation Agreement with Broadwood Partners, L.P. referenced in the filing.
- Monitor future filings for the appointment of a permanent CEO and any resulting changes to the interim compensation structure.
- Confirm the vesting schedules and acceleration triggers for the RSUs and PSUs granted to the interim leadership.